CELL LINE DEVELOPMENT
CELL LINE DEVELOPMENT
CELL BANKING
CELL BANKING
PROCESS DEVELOPMENT
PROCESS DEVELOPMENT
TECH TRANSFER
TECH TRANSFER
SCALE UP & GMP MANUFACTURING
SCALE UP & GMP MANUFACTURING
COMMERCIAL MANUFACTURING
COMMERCIAL MANUFACTURING

DEVELOPMENT

PRE-CLINICAL SUPPLY

CLINICAL SUPPLY

MARKET SUPPLY

Cell line development

We take care for the most important part of your process and what it’s most critical for a successful development program: your cell line. Knowing how important this activity is, and how a good starting point makes the difference between success and failure, we offer you the management of all this activity, from the amino acid (or nucleotide) sequence of your protein, to the generation of a stable Research Cell Bank (RCB) that will be characterized to a point in which we will have confidence to succeed in the development program. Taking into account that this activity is key for the CMC preparation, 3P ensures full traceability of all the operations performed , as well as a complete history of the cell line, vector and plasmid used to construct the final RCB.

Process Development

Robust and scalable processes

Time makes the difference in healing as well as the time to the market with your biologics. 3P’s highly experienced professionals are always focused on the development of scalable, efficient processes that will be smoothly transferred to our larger scales in order to minimize the time-to-market global schedule. We know that the time “spent” in our laboratory is an investment for the future and our development platforms have demonstrated a robust, scalable and well controlled process that results in reproducible processes when facing non-clinical and clinical phases.

Our dedicated team of scientists and analysts have obtained the skills and knowledge to develop processes to meet your project goals in a high-quality and cost-effective way.

Our unique combination of knowhow, the latest technologies, equipment and our team spirit allows us driving your product development and moving it to the market.

  • INDUSTRIAL VISION
  • REPRODUCIBLE
  • EFFICIENT
  • SCALABLE

Process development capacities:

  • Microbioreactor AMBR 15, 24 vessels
  • Biostat Q 6x1L
  • Biostat B: 2x2L+1x5L
  • Biostat B twin 2x5L

GMP Manufacturing

The future of biopharmaceuticals

The manufacture of mammalian biopharmaceuticals has become a major global enterprise. We are committed to drive your mammalian manufacturing to succees.
3P Biopharmaceutical’s manufacturing facilities provides single-use technology for cost-effective production reducing risk of cross contamination and faster manufacturing.

Cell line experience

  • CHO
  • NS0
  • BHK
  • HEK
  • Hybridomas
  • Other cell types

Single use bioreactor capacities